Indication
Treatment of breast and ovarian cancer.
Official EMA Resources
View on EMA (ema.europa.eu)AI Drug & Interaction Analysis
Loading your page…
Loading your page…
Breast Neoplasms;Ovarian Neoplasms
Marketing Authorisation Holder: TLC Biopharmaceuticals B.V.
INN: doxorubicin
AI Drug & Interaction Analysis
Free account required
Ask Osler about Doxolipad: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.